The G20 Global Pharma Summit Series-Canada has brought a renewed focus on sustainability and green initiatives in the pharmaceutical industry. Recognizing the environmental impact of pharmaceutical production, the summit emphasized the need for sustainable practices and green chemistry in drug development and manufacturing.
Key discussions revolved around reducing waste, minimizing energy use, and promoting the use of renewable resources. The industry was urged to adopt cleaner production processes, invest in eco-friendly technologies, and develop drugs that are safe for both the environment and human health.
The summit highlighted the role of the pharmaceutical industry in achieving the Sustainable Development Goals (SDGs) set by the United Nations. It underscored the need for a collaborative approach, involving governments, industry players, and civil society, to drive the green transformation of the pharmaceutical industry.